Screening colonoscopy: Should we focus more on technique and less on technology?

F1000Prime Reports

Volumn 5, Issue , 2013, Pages

  Mohammed, Noor ^a   Subramanian, Venkataraman ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; MACROGOL; SCOPOLAMINE BUTYL BROMIDE;

ARTICLE; BODY POSITION; CANCER DIAGNOSIS; CANCER SCREENING; CHROMOENDOSCOPY; COLON LAVAGE; COLONOSCOPE; COLONOSCOPY; COLORECTAL CANCER; HUMAN; MEDICAL PROCEDURES; OPERATOR; VIDEORECORDING;

EID: 84883181515     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P5-32     Document Type: Article

References (40)

1. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L: Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008, 103:1541-9. (Pubitemid 351813919)
2. Winawer SJ, Zauber AG, Ho MN,O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp StudyWorkgroup. N Engl J Med 1993, 329:1977-81. (Pubitemid 24015040)
3. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L: Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009, 150:1-8.
4. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U: Protection from right- and left-sided colorectalneoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010, 102:89-95.
5. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E: Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010, 362:1795-803.
6. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD: Colonoscopic polypectomy and longterm prevention of colorectal-cancer deaths. N Engl J Med 2012, 366:687-96.
7. Calderwood AH, Jacobson BC: Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointest Endosc 2010, 72:686-92.
8. Hillyer GC, Basch CH, Basch CE, Lebwohl B, Kastrinos F, Insel BJ, Neugut AI: Gastroenterologists' perceived barriers to optimal pre-colonoscopy bowel preparation: results of a national survey. J Cancer Educ 2012, 27:526-32.
9. Belsey J, Crosta C, Epstein O, Fischbach W, Layer P, Parente F, Halphen M: Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther 2012, 35:222-37.
10. Enestvedt BK, Tofani C, Laine LA, Tierney A, Fennerty MB: 4-Liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol 2012, 10:1225-31.
11. Gurudu SR, Ramirez FC, Harrison ME, Leighton JA, Crowell MD: Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy. Gastrointest Endosc 2012, 76:603-8.e1.
12. Flemming JA, Vanner SJ, Hookey LC: Split-dose picosulfate, magnesium oxide, and citric acid solution markedly enhances colon cleansing before colonoscopy: a randomized, controlled trial. Gastrointest Endosc 2012, 75:537-44.
13. Seo EH, Kim TO, Park MJ, Joo HR, Heo NY, Park J, Park SH, Yang SY, Moon YS: Optimal preparation-to-colonoscopy interval in split-dose PEG bowel preparation determines satisfactory bowel preparation quality: an observational prospective study. Gastrointest Endosc 2012, 75:583-90.
14. Lurix E, Hernandez AV, Thoma M, Castro F: Adenoma detection rate is not influenced by full-day blocks, time, or modified queue position. Gastrointest Endosc 2012, 75:827-34.
15. Gurudu SR, Ratuapli SK, Leighton JA, Heigh RI, Crowell MD: Adenoma detection rate is not influenced by the timing of colonoscopy when performed in half-day blocks. Am J Gastroenterol 2011, 106:1466-71.
16. Lee A, Iskander JM, Gupta N, Borg BB, Zuckerman G, Banerjee B, Gyawali CP: Queue position in the endoscopic schedule impacts effectiveness of colonoscopy. Am J Gastroenterol 2011, 106:1457-65.
17. Long MD, Martin C, Sandler RS, Herfarth HH, Shaheen NJ, Dellon ES: Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol 2011, 45:253-8.
18. East JE, Suzuki N, Arebi N, Bassett P, Saunders BP: Position changes improve visibility during colonoscope withdrawal: a randomized, blinded, crossover trial. Gastrointest Endosc 2007, 65:263-9. (Pubitemid 46148890)
19. East JE, Bassett P, Arebi N, Thomas-Gibson S, Guenther T, Saunders BP: Dynamic patient position changes during colonoscope withdrawal increase adenoma detection: a randomized, crossover trial. Gastrointest Endosc 2011, 73:456-63.
20. Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mroß M, ScheelM, SchröderA,GerberK, StangeG, Roll S, Gauger U, Wiedenmann B, Altenhofen L, Rosch T: Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut 2013, 62:236-41.
21. Lee RH, Tang RS, Muthusamy VR, Ho SB, Shah NK, Wetzel L, Bain AS, Mackintosh EE, Paek AM, Crissien AM, Saraf LJ, Kalmaz DM, Savides TJ: Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos). Gastrointest Endosc 2011, 74:128-34.
22. Gromski MA, Miller CA, Lee S, Park ES, Lee TH, Park S, Chung I, Kim S, Hwangbo Y: Trainees' adenoma detection rate is higher if ≥ 10 minutes is spent on withdrawal during colonoscopy. Surg Endosc 2012, 26:1337-42.
23. Overholt BF, Brooks-Belli L, Grace M, Rankin K, Harrell R, Turyk M, Rosenberg FB, Barish RW, Gilinsky NH: Withdrawal times and associated factors in colonoscopy: a quality assurance multicenter assessment. J Clin Gastroenterol 2010, 44:e80-6.
24. Buchner AM, Shahid MW, Heckman MG, Diehl NN, McNeil RB, Cleveland P, Gill KR, Schore A, Ghabril M, Raimondo M, Gross SA, Wallace MB: Trainee participation is associated with increased small adenoma detection. Gastrointest Endosc 2011, 73:1223-31.
25. Eckardt AJ, Swales C, Bhattacharya K, Wassef WY, Leung K, Levey JM: Does trainee participation during colonoscopy affect adenoma detection rates? Dis Colon Rectum 2009, 52:1337-44.
26. Rex DK, Hewett DG, Raghavendra M, Chalasani N: The impact of videorecording on the quality of colonoscopy performance: a pilot study. Am J Gastroenterol 2010, 105:2312-7.
27. Madhoun MF, Tierney WM: The impact of video recording colonoscopy on adenoma detection rates. Gastrointest Endosc 2012, 75:127-33.
28. Saad A, Rex D: Routine rectal retroflexion during colonoscopy has a low yield for neoplasia. World J Gastroenterol 2008, 14:6503-5.
29. Rex DK: Accessing proximal aspects of folds and flexures during colonoscopy: impact of a pediatric colonoscope with a short bending section. Am J Gastroenterol 2003, 98:1504-7. (Pubitemid 36875340)
30. Harrison M, Singh N, Rex DK: Impact of proximal colon retroflexion on adenoma miss rates. Am J Gastroenterol 2004, 99:519-22. (Pubitemid 38524133)
31. Hewett DG, Rex DK: Inspection on instrument insertion during colonoscopy: a randomized controlled trial. Gastrointest Endosc 2012, 76:381-7.
32. Wildi SM, Schoepfer AM, Vavricka SR, Fruehauf H, Safroneeva E, Wiegand N, Bauerfeind P, Fried M: Colorectal polypectomy during insertion and withdrawal or only during withdrawal? A randomized controlled trial. Endoscopy 2012, 44:1019-23.
33. Brouwer EJ de, Arbouw ME, van der Zwet WC, van Herwaarden MA, Ledeboer M, Jansman FG, ter Borg F: Hyoscine N-butylbromide does not improve polyp detection during colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial. Gastrointest Endosc 2012, 75:835-40.
34. Corte C, Dahlenburg L, Selby W, Griffin S, Byrne C, Chua T, Kaffes A: Hyoscine butylbromide administered at the cecum increases polyp detection: a randomized double-blind placebocontrolled trial. Endoscopy 2012, 44:917-22.
35. Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM: Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer 2012, 118:3044-52.
36. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L: Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 2011, 140:65-72.
37. Singh H, Nugent Z, Demers AA, Bernstein CN: Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 2010, 105:2588-96.
38. Bhangu A, Bowley DM, Horner R, Baranowski E, Raman S, Karandikar S: Volume and accreditation, but not specialty, affect quality standards in colonoscopy. Br J Surg 2012, 99:1436-44.
39. Coe SG, Crook JE, Diehl NN, Wallace MB: An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol 2013, 108:219-26 quiz 227.
40. Shaukat A, Oancea C, Bond JH, Church TR, Allen JI: Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program. Clin Gastroenterol Hepatol 2009, 7:1335-40.